TRIPLE THERAPY WITH ASPIRIN, PRASUGREL AND VITAMIN K ANTAGONISTS IN PATIENTS WITH DRUG ELUTING STENT IMPLANTATION AND AN INDICATION FOR ORAL ANTICOAGULATION

TRIPLE THERAPY WITH ASPIRIN, PRASUGREL AND VITAMIN K ANTAGONISTS IN PATIENTS WITH DRUG ELUTING STENT IMPLANTATION AND AN INDICATION FOR ORAL ANTICOAGULATION

The secondary endpoint was a composite of death, MI, ischemic stroke and definite stent thrombosis.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American College of Cardiology 2013-03, Vol.61 (10), p.E1859-E1859
Hauptverfasser: Sarafoff, Nikolaus, Martischnig, Amadea, Wealer, Jill, Mayer, Katharina, Mehilli, Julinda, Sibbing, Dirk, Kastrati, Adnan, Herzzentrum, Deutsches
Format: Artikel
Sprache:eng
Schlagworte:
Cardiology
Cardiovascular
Coagulation
Drug therapy
HIV
Human immunodeficiency virus
Internal Medicine
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The secondary endpoint was a composite of death, MI, ischemic stroke and definite stent thrombosis.
ISSN:0735-1097
1558-3597
DOI:10.1016/S0735-1097(13)61859-8